nodes	percent_of_prediction	percent_of_DWPC	metapath
Alimemazine—Cardiac fibrillation—Lisinopril—systemic scleroderma	0.0463	0.0463	CcSEcCtD
Alimemazine—Pallor—Captopril—systemic scleroderma	0.0206	0.0206	CcSEcCtD
Alimemazine—Jaundice cholestatic—Captopril—systemic scleroderma	0.0194	0.0194	CcSEcCtD
Alimemazine—Nasal congestion—Pentoxifylline—systemic scleroderma	0.0179	0.0179	CcSEcCtD
Alimemazine—Pallor—Leflunomide—systemic scleroderma	0.017	0.017	CcSEcCtD
Alimemazine—Jaundice cholestatic—Azathioprine—systemic scleroderma	0.017	0.017	CcSEcCtD
Alimemazine—Pallor—Mycophenolic acid—systemic scleroderma	0.0162	0.0162	CcSEcCtD
Alimemazine—Nasal congestion—Mometasone—systemic scleroderma	0.0155	0.0155	CcSEcCtD
Alimemazine—Jaundice cholestatic—Mycophenolic acid—systemic scleroderma	0.0153	0.0153	CcSEcCtD
Alimemazine—Gynaecomastia—Captopril—systemic scleroderma	0.0153	0.0153	CcSEcCtD
Alimemazine—Photosensitivity—Captopril—systemic scleroderma	0.0141	0.0141	CcSEcCtD
Alimemazine—Jaundice cholestatic—Lisinopril—systemic scleroderma	0.0138	0.0138	CcSEcCtD
Alimemazine—Ventricular tachycardia—Mycophenolic acid—systemic scleroderma	0.0134	0.0134	CcSEcCtD
Alimemazine—Pallor—Mycophenolate mofetil—systemic scleroderma	0.0128	0.0128	CcSEcCtD
Alimemazine—Jaundice—Pentoxifylline—systemic scleroderma	0.0123	0.0123	CcSEcCtD
Alimemazine—Ventricular tachycardia—Lisinopril—systemic scleroderma	0.0121	0.0121	CcSEcCtD
Alimemazine—Amenorrhoea—Mycophenolate mofetil—systemic scleroderma	0.0121	0.0121	CcSEcCtD
Alimemazine—Jaundice cholestatic—Mycophenolate mofetil—systemic scleroderma	0.0121	0.0121	CcSEcCtD
Alimemazine—Orthostatic hypotension—Captopril—systemic scleroderma	0.0113	0.0113	CcSEcCtD
Alimemazine—Eosinophilia—Captopril—systemic scleroderma	0.0106	0.0106	CcSEcCtD
Alimemazine—Ventricular tachycardia—Mycophenolate mofetil—systemic scleroderma	0.0106	0.0106	CcSEcCtD
Alimemazine—Arrhythmia—Pentoxifylline—systemic scleroderma	0.0101	0.0101	CcSEcCtD
Alimemazine—Photosensitivity—Lisinopril—systemic scleroderma	0.00999	0.00999	CcSEcCtD
Alimemazine—Erectile dysfunction—Captopril—systemic scleroderma	0.00986	0.00986	CcSEcCtD
Alimemazine—Photosensitivity reaction—Captopril—systemic scleroderma	0.00977	0.00977	CcSEcCtD
Alimemazine—Nasal congestion—Lisinopril—systemic scleroderma	0.00963	0.00963	CcSEcCtD
Alimemazine—Gynaecomastia—Mycophenolate mofetil—systemic scleroderma	0.00947	0.00947	CcSEcCtD
Alimemazine—Jaundice—Captopril—systemic scleroderma	0.00931	0.00931	CcSEcCtD
Alimemazine—Hypokalaemia—Leflunomide—systemic scleroderma	0.00929	0.00929	CcSEcCtD
Alimemazine—Tremor—Pentoxifylline—systemic scleroderma	0.00922	0.00922	CcSEcCtD
Alimemazine—Agitation—Pentoxifylline—systemic scleroderma	0.00905	0.00905	CcSEcCtD
Alimemazine—Agranulocytosis—Captopril—systemic scleroderma	0.00891	0.00891	CcSEcCtD
Alimemazine—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.0089	0.0089	CcSEcCtD
Alimemazine—Hypokalaemia—Mycophenolic acid—systemic scleroderma	0.00886	0.00886	CcSEcCtD
Alimemazine—Eosinophilia—Leflunomide—systemic scleroderma	0.00874	0.00874	CcSEcCtD
Alimemazine—Convulsion—Pentoxifylline—systemic scleroderma	0.00853	0.00853	CcSEcCtD
Alimemazine—Dry mouth—Pentoxifylline—systemic scleroderma	0.0082	0.0082	CcSEcCtD
Alimemazine—Amenorrhoea—Prednisone—systemic scleroderma	0.00817	0.00817	CcSEcCtD
Alimemazine—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.00801	0.00801	CcSEcCtD
Alimemazine—Infection—Pentoxifylline—systemic scleroderma	0.00798	0.00798	CcSEcCtD
Alimemazine—Agranulocytosis—Azathioprine—systemic scleroderma	0.00778	0.00778	CcSEcCtD
Alimemazine—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.00775	0.00775	CcSEcCtD
Alimemazine—Jaundice—Leflunomide—systemic scleroderma	0.00767	0.00767	CcSEcCtD
Alimemazine—Eosinophilia—Lisinopril—systemic scleroderma	0.00751	0.00751	CcSEcCtD
Alimemazine—Hypotension—Pentoxifylline—systemic scleroderma	0.00751	0.00751	CcSEcCtD
Alimemazine—Agranulocytosis—Leflunomide—systemic scleroderma	0.00734	0.00734	CcSEcCtD
Alimemazine—Jaundice—Mycophenolic acid—systemic scleroderma	0.00732	0.00732	CcSEcCtD
Alimemazine—Insomnia—Pentoxifylline—systemic scleroderma	0.00727	0.00727	CcSEcCtD
Alimemazine—Dry mouth—Mometasone—systemic scleroderma	0.00707	0.00707	CcSEcCtD
Alimemazine—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00702	0.00702	CcSEcCtD
Alimemazine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.007	0.007	CcSEcCtD
Alimemazine—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.007	0.007	CcSEcCtD
Alimemazine—Erectile dysfunction—Lisinopril—systemic scleroderma	0.00698	0.00698	CcSEcCtD
Alimemazine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00692	0.00692	CcSEcCtD
Alimemazine—Infection—Mometasone—systemic scleroderma	0.00689	0.00689	CcSEcCtD
Alimemazine—Arrhythmia—Azathioprine—systemic scleroderma	0.00668	0.00668	CcSEcCtD
Alimemazine—Jaundice—Lisinopril—systemic scleroderma	0.00659	0.00659	CcSEcCtD
Alimemazine—Cardiac disorder—Leflunomide—systemic scleroderma	0.00656	0.00656	CcSEcCtD
Alimemazine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00635	0.00635	CcSEcCtD
Alimemazine—Arrhythmia—Leflunomide—systemic scleroderma	0.00631	0.00631	CcSEcCtD
Alimemazine—Agranulocytosis—Lisinopril—systemic scleroderma	0.00631	0.00631	CcSEcCtD
Alimemazine—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00625	0.00625	CcSEcCtD
Alimemazine—Dry mouth—Captopril—systemic scleroderma	0.00621	0.00621	CcSEcCtD
Alimemazine—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.00612	0.00612	CcSEcCtD
Alimemazine—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00602	0.00602	CcSEcCtD
Alimemazine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00577	0.00577	CcSEcCtD
Alimemazine—Hypotension—Captopril—systemic scleroderma	0.00569	0.00569	CcSEcCtD
Alimemazine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00553	0.00553	CcSEcCtD
Alimemazine—Insomnia—Captopril—systemic scleroderma	0.00551	0.00551	CcSEcCtD
Alimemazine—Tremor—Mycophenolic acid—systemic scleroderma	0.0055	0.0055	CcSEcCtD
Alimemazine—Body temperature increased—Mometasone—systemic scleroderma	0.00548	0.00548	CcSEcCtD
Alimemazine—Arrhythmia—Lisinopril—systemic scleroderma	0.00542	0.00542	CcSEcCtD
Alimemazine—Agitation—Mycophenolic acid—systemic scleroderma	0.00539	0.00539	CcSEcCtD
Alimemazine—Gynaecomastia—Methotrexate—systemic scleroderma	0.00537	0.00537	CcSEcCtD
Alimemazine—Infection—Azathioprine—systemic scleroderma	0.00528	0.00528	CcSEcCtD
Alimemazine—Dry mouth—Leflunomide—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Alimemazine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Alimemazine—Rash—Pentoxifylline—systemic scleroderma	0.00507	0.00507	CcSEcCtD
Alimemazine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00506	0.00506	CcSEcCtD
Alimemazine—Infection—Leflunomide—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Alimemazine—Hypotension—Azathioprine—systemic scleroderma	0.00497	0.00497	CcSEcCtD
Alimemazine—Photosensitivity—Methotrexate—systemic scleroderma	0.00496	0.00496	CcSEcCtD
Alimemazine—Tremor—Lisinopril—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Alimemazine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00494	0.00494	CcSEcCtD
Alimemazine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00492	0.00492	CcSEcCtD
Alimemazine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00488	0.00488	CcSEcCtD
Alimemazine—Body temperature increased—Captopril—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Alimemazine—Infection—Mycophenolic acid—systemic scleroderma	0.00476	0.00476	CcSEcCtD
Alimemazine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00475	0.00475	CcSEcCtD
Alimemazine—Hypokalaemia—Prednisone—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Alimemazine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00469	0.00469	CcSEcCtD
Alimemazine—Hypotension—Leflunomide—systemic scleroderma	0.00469	0.00469	CcSEcCtD
Alimemazine—Insomnia—Leflunomide—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Alimemazine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Alimemazine—Dry mouth—Lisinopril—systemic scleroderma	0.0044	0.0044	CcSEcCtD
Alimemazine—Rash—Mometasone—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Alimemazine—Dermatitis—Mometasone—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Alimemazine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Alimemazine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00433	0.00433	CcSEcCtD
Alimemazine—Infection—Lisinopril—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Alimemazine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Alimemazine—Body temperature increased—Azathioprine—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Alimemazine—Erectile dysfunction—Prednisone—systemic scleroderma	0.00415	0.00415	CcSEcCtD
Alimemazine—Hypotension—Lisinopril—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Alimemazine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Alimemazine—Body temperature increased—Leflunomide—systemic scleroderma	0.00397	0.00397	CcSEcCtD
Alimemazine—Insomnia—Lisinopril—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Alimemazine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00385	0.00385	CcSEcCtD
Alimemazine—Rash—Captopril—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Alimemazine—Dermatitis—Captopril—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Alimemazine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Alimemazine—Infection—Mycophenolate mofetil—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Alimemazine—Eosinophilia—Methotrexate—systemic scleroderma	0.00373	0.00373	CcSEcCtD
Alimemazine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00371	0.00371	CcSEcCtD
Alimemazine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Alimemazine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00347	0.00347	CcSEcCtD
Alimemazine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Alimemazine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00342	0.00342	CcSEcCtD
Alimemazine—Body temperature increased—Lisinopril—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Alimemazine—Rash—Azathioprine—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Alimemazine—Dermatitis—Azathioprine—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Alimemazine—Arrhythmia—Prednisone—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Alimemazine—Rash—Leflunomide—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Alimemazine—Dermatitis—Leflunomide—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Alimemazine—Agranulocytosis—Methotrexate—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Alimemazine—Rash—Mycophenolic acid—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Alimemazine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Alimemazine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Alimemazine—Agitation—Prednisone—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Alimemazine—Cardiac disorder—Methotrexate—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Alimemazine—Rash—Lisinopril—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Alimemazine—Convulsion—Prednisone—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Alimemazine—Dermatitis—Lisinopril—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Alimemazine—Infection—Prednisone—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Alimemazine—Nervous system disorder—Prednisone—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Alimemazine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Alimemazine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Alimemazine—Insomnia—Prednisone—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Alimemazine—Convulsion—Methotrexate—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Alimemazine—Infection—Methotrexate—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Alimemazine—Nervous system disorder—Methotrexate—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Alimemazine—Body temperature increased—Prednisone—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Alimemazine—Hypotension—Methotrexate—systemic scleroderma	0.002	0.002	CcSEcCtD
Alimemazine—Insomnia—Methotrexate—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Alimemazine—Body temperature increased—Methotrexate—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Alimemazine—Rash—Prednisone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Alimemazine—Dermatitis—Prednisone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Alimemazine—Rash—Methotrexate—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Alimemazine—Dermatitis—Methotrexate—systemic scleroderma	0.00135	0.00135	CcSEcCtD
